GGrantIndex
← Search

BIOAVAILABILITY OF URSOCARB COMPARED TO ACTIGALL IN LIVER DISEASE AND CF

$590M01FY2006RRNIH

Cincinnati Childrens Hosp Med Ctr, Cincinnati OH

Investigators

Linked publications & trials

View original record on NIH RePORTER →